View study details on clinicaltrials.gov.
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
A Phase II Double-Blinded, Placebo-Controlled Trial of PROstate OligoMETastatic RadiotHErapy With or Without ANdrogen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG Promethean)
Genomic Health Oncotype DX AR-V7
Investigators: Vijay Suhag, M.D., Kristie A. Bobolis, M.D., David S Yee, M.D., MPH, Nitin Rohatgi, MD, Kristin N. Arreola, M.D., Sivakumar Reddy, M.D., Brian K. Kim, M.D, Rajeswari Chellappah, M.D.